Discontinued GLP-1 agonists: 1
On the basis of results of the most recent CVOTs (DAPA-HF, DAPA-CKD, EMPEROR-R), the FDA has approved dapagliflozin (2020) and empagliflozin (2021) to reduce risk for CV death and HF hospitalization in adults with HF and reduced ejection fraction regardless of whether they have diabetes [24, 25]
These discussions often center on everyday experiences with GLP-1 medications, including how dosing choices affect comfort, cost, and consistency
Step 2: Explain GLP-1 and Its Function Clearly explain what GLP-1 is and how it works in simple terms
JAMA Intern Med 2013;173:534-9.ArticlePubMed 60
Finding the Right GLP-1 Medication for You At Laser Beauty Works, we believe weight loss isnt one-size-fits-all, which is why we offer two trusted GLP-1 options: Semaglutide and Tirzepatide